Partner Headlines - LLY

  1. Veeva Systems Flies High On Cloud For Life Sciences

    IBD
  2. Sanofi Axes CEO, Hit By Multiple Downgrades

    IBD
  3. French Drugmaker Sanofi Warns Of Tougher Competition

    IBD
  4. US Stock Futures Rise Ahead Of Earnings, Economic Data

    Benzinga
  5. Earnings Scheduled For October 23, 2014

    Benzinga
  6. CANDA NK-2 Files Motion To Dismiss Patent Infringement Suit

    Benzinga
  7. Lilly, Zymeworks Announce Expansion Of Strategic Licensing And ...

    Benzinga
  8. Benzinga Weekly Preview: Earnings Season Is In Full Swing

    Benzinga
  9. Celgene, Alexion Among 4 IBD 50 Medical s To Report

    IBD
  10. UPDATE: Lilly To Initiate Efforts To Sell Guayama Site

    Benzinga
  11. Lilly Announces Plan to Realign Puerto Rico Manufacturing Operations

    Benzinga
  12. Drug Analysts Mull End Of 'Double Irish' Loophole

    IBD
  13. Pharma Stocks: Surprising Shift In U.S. Drug Market

    YCharts
  14. Meet 5 Top International Stocks Not Based In China

    IBD
  15. Dyax Offers Highlights of Recent Progress in Licensing, Funded-Research ...

    Benzinga
  16. Lipocine Inc Halted: Feds Eye Safety, Efficacy Of Testosterone

    Benzinga
  17. Drug giants target Alzheimer's

    IBD
  18. What Is A High Risk Market?

    Benzinga
  19. Higher Yielding Stocks With A Cheap EV/EBITDA Ratio And Low Debt ...

    GuruFocus
  20. Markets Little Changed In Low Volume And Slow News Ahead Of Long ...

    Benzinga
  21. Deutsche Bank: Eli Lilly At 'Critical Stage' In Its Journey

    Benzinga
  22. Deutsche Bank Starts Pfizer, Lilly at Buy, Merck, Bristol-Myers ...

    Benzinga
  23. New Type 2 Diabetes Treatment Jardiance Tablets For Adults Now ...

    Benzinga
  24. UPDATE: Tigress Initiates Coverage On Eli Lilly

    Benzinga
  25. Dow Suffers 300 Point Drop; S&P 500 And Nasdaq Also Tumble

    Benzinga
  26. Stocks Lower As Earnings Season Takes Back Seat To Geopolitical ...

    Benzinga
  27. Thursday Morning Earnings Reports

    Benzinga
  28. Earnings Scheduled For July 24, 2014

    Benzinga
  29. New Study Shows Beta-Amyloid Imaging Is Associated With Altered ...

    Benzinga
  30. Lilly And Immunocore Enter Immunotherapy Agreement To Co-Discover ...

    Benzinga
  31. Benzinga's Top #PreMarket Gainers

    Benzinga
  32. US Stock Futures Mostly Higher Ahead Of Goldman Sachs Earnings

    Benzinga
  33. Barclays Downgrades Pharmaceutical Sector

    Benzinga
  34. UPDATE: Barclays Upgrades Eli Lilly Despite Sector Downgrade

    Benzinga
  35. Benzinga's Top Upgrades

    Benzinga
  36. Eli Lilly is on the Right Track

    GuruFocus
  37. Celgene Sees Better Results For Psoriatic Arthritis

    IBD
  38. Eli Lilly Bets Big on Diabetes, Cancer Drugs

    FoxBusiness
  39. Novo Nordisk Raises Insulin Prices As Demand Grows

    IBD
  40. ASCO Meeting Day 3: Do More Treatments Equal A Longer Life?

    Benzinga
  41. ASCO Meeting Day 2: 'Promising' Results From JNJ's Imbruvica ...

    Benzinga
  42. John Paulson's 4 Stocks Trading for Less Than He Paid for Them

    GuruFocus
  43. Lilly Says Abemaciclib in Phase 1 Study Demonstrated Single-Agent ...

    Benzinga
  44. Eli Lilly insulin trial succeeds

    IBD
  45. Cross-Border Megamergers Drive Global Takeover Boom

    IBD
  46. Google Celebrates Dorothy Hodgkin & Her Contributions To Chemistry

    Benzinga
  47. Eli Lilly's Basal Insulin Outperforms Lantus In Trial

    IBD
  48. UPDATE: Eli Lilly Announces Peglispro Shows Superiority Compared ...

    Benzinga
  49. Can Pfizer Make Up Its Loss?

    GuruFocus
  50. Merck Sells Consumer Unit To Bayer To Focus On R&D

    IBD
  51. Bayer Buys Merck Consumer Care Unit

    FoxBusiness
  52. Will Pfizer's Q1 2014 Earnings Beat the Street on May 5, 2014?

    GuruFocus
  53. AstraZeneca Rejects Pfizer's $106B Buyout Bid

    FoxBusiness
  54. Novo Nordisk Struggles In U.S. Market; Q1 Sales Miss

    IBD
  55. Novo Nordisk Q1 Revenue Misses; Guidance Lowered

    IBD
  56. Vanguard Health Care Fund's Top Quarterly Holdings

    GuruFocus
  57. Actavis Earns Over-The-Top Q1

    IBD
  58. Actavis Beats Q1 Views, Looks To Supersized Future

    IBD
  59. Actavis Q1 Earnings Beat On Generic Cymbalta Surprise

    IBD
  60. China Rule Change Further Opens Yuan To World Markets

    IBD
  61. These Three Pharmaceutical Companies Shake The Market With Their ...

    GuruFocus
  62. Drugmakers' Q1 was anemic

    IBD
  63. Eli Lilly Jr. Made His Firm A Pharmaceutical Power

    IBD
  64. Earnings Scheduled For April 24, 2014

    Benzinga
  65. Big Pharmas Swap Specialties

    IBD
  66. Drugmakers Prod European Stocks To Post-Easter Rally

    IBD
  67. Benzinga's M&A Chatter for Tuesday April 22, 2014

    Benzinga
  68. Novartis, Glaxo Swap Units; Valeant Bids For Allergan

    IBD
  69. Stocks Rise In Higher Volume; Gilead Up After Hours

    IBD
  70. Pharma Deal Frenzy: A Bid to Boost Profits, Cut Risk

    FoxBusiness
  71. Amgen Slumps After 1Q Earnings Miss

    FoxBusiness
  72. Novartis, Glaxo Swap Units; Lilly Buying Animal Biz

    IBD
  73. Stock Futures Mixed And Busy; Allergan, Netflix, Glaxo Climb

    IBD
  74. Novartis Announces Multi-Billion-Dollar Revamp

    FoxBusiness
  75. US Stock Futures Edge Higher Ahead Of McDonald's Earnings

    Benzinga
  76. Wall Street Ticks Up as Traders Parse News Deluge

    FoxBusiness
  77. Stock Futures Steady Amid Raft of Health M&A

    FoxBusiness
  78. ELI LILLY

    IBD
  79. No Legwork Mondays – Takeda, Eli Lilly, And Actos

    Benzinga
  80. Market Wrap For April 14: Markets Surge on Positive Retail Data, ...

    Benzinga
  81. Lilly, Takeda must pay $9 bil

    IBD
  82. Ethical Drug Stocks Are Struggling

    IBD
  83. UPDATE: BMO Capital Upgrades Eli Lilly

    Benzinga
  84. Takeda, Lilly to 'Vigorously Challenge' Actos Ruling

    FoxBusiness
  85. Benzinga's Top Upgrades

    Benzinga
  86. Takeda Responds to $6B Verdict in Diabetes Drug Case

    Benzinga
  87. Top 4 NYSE Stocks In The Drug Manufacturers-Major Industry With ...

    Benzinga
  88. Pfizer Breast-Cancer Drug Scores, But Street Cautious

    IBD
  89. Market Wrap For April 3: Markets Winning Streak Fails To Extend ...

    Benzinga
  90. Wide Moat Stocks: Protection In A Correction

    YCharts
  91. UPDATE: Cowen & Company Upgrades Eli Lilly

    Benzinga
  92. Benzinga's Top Upgrades

    Benzinga
  93. Biotech Auxilium Boosts Position In Men's Health Care

    IBD
  94. Lilly Expands Generic Deal With Prasco

    FoxBusiness
  95. UPDATE: Bank of America Reiterates on Eli Lilly and Co. Following ...

    Benzinga
  96. Merck Snags Baxter Executive As CFO

    FoxBusiness
  97. Box, Online Storage Service Provider, Files For IPO

    IBD
  98. Which Pharmas Can Keep Up Dividend-Buybacks?

    YCharts
  99. Forest Laboratories' Recovery

    GuruFocus
  100. Pfizer Breast-Cancer Drug To Show If It's For Real

    IBD
Trading Center